DocCheck AG (XETRA:AJ91) — Stock Price
DocCheck AG (XETRA:AJ91) is currently trading at €11.40 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €10.80 and €15.40. This page tracks DocCheck AG's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see AJ91 market cap.
DocCheck AG (AJ91) Stock Price Chart — Daily History & Trading Volume
The chart below tracks DocCheck AG's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.
DocCheck AG Income Statement — Revenue, Profit & Earnings by Year
DocCheck AG's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €55.32 Million | €53.79 Million | €53.41 Million | €60.90 Million | €85.92 Million |
| Cost of Revenue | €43.04 Million | €43.26 Million | €40.44 Million | €46.82 Million | €64.38 Million |
| Gross Profit | €12.28 Million | €10.53 Million | €12.97 Million | €14.08 Million | €21.54 Million |
| Research & Development | — | — | — | — | — |
| SG&A | — | €607.00K | €662.00K | €617.00K | €755.00K |
| Total Operating Expenses | €4.67 Million | €4.06 Million | €9.43 Million | €4.86 Million | €4.88 Million |
| Operating Income | €7.61 Million | €6.47 Million | €3.54 Million | €10.41 Million | €16.66 Million |
| EBITDA | €10.39 Million | €10.18 Million | €9.38 Million | €13.38 Million | €20.09 Million |
| EBIT | €7.61 Million | €7.75 Million | €4.51 Million | €10.53 Million | €17.53 Million |
| Interest Expense | €411.44K | €190.18K | €126.72K | €1.21 Million | €243.93K |
| Income Before Tax | €8.34 Million | €7.56 Million | €4.38 Million | €9.32 Million | €17.29 Million |
| Income Tax Expense | €3.01 Million | €2.27 Million | €2.25 Million | €3.05 Million | €5.46 Million |
| Net Income | €5.33 Million | €5.28 Million | €2.27 Million | €6.29 Million | €11.40 Million |
DocCheck AG Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes DocCheck AG's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €55.68 Million | €60.86 Million | €56.14 Million | €63.28 Million | €60.25 Million |
| Total Current Assets | €33.92 Million | €37.74 Million | €34.46 Million | €35.21 Million | €36.31 Million |
| Cash & Equivalents | — | €17.02 Million | €14.36 Million | €13.39 Million | €18.19 Million |
| Short-term Investments | €4.06 Million | €4.00 Million | €3.15 Million | €2.27 Million | €3.33 Million |
| Net Receivables | €11.04 Million | €12.77 Million | €9.85 Million | €11.95 Million | €10.17 Million |
| Inventory | €3.61 Million | €3.31 Million | €3.21 Million | €3.35 Million | €3.64 Million |
| Property, Plant & Equipment | — | €14.34 Million | €15.83 Million | €19.21 Million | €13.71 Million |
| Goodwill | €19.74K | €19.74K | €19.74K | €19.74K | €19.74K |
| Total Liabilities | €14.07 Million | €20.78 Million | €18.11 Million | €23.86 Million | €22.08 Million |
| Total Current Liabilities | €10.66 Million | €13.79 Million | €12.99 Million | €14.17 Million | €12.07 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | €-10.32 Million | €-12.01 Million | €-8.51 Million | €-6.31 Million | €-11.16 Million |
| Total Stockholder Equity | €41.61 Million | €40.08 Million | €37.33 Million | €38.57 Million | €37.31 Million |
| Retained Earnings | €26.22 Million | €24.69 Million | €21.94 Million | €23.46 Million | €22.20 Million |
DocCheck AG Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how DocCheck AG generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €6.14 Million | €7.64 Million | €7.51 Million | €5.95 Million | €10.93 Million |
| Capital Expenditures | €3.53 Million | €997.23K | €1.89 Million | €6.45 Million | €4.02 Million |
| Free Cash Flow | €2.61 Million | €6.82 Million | €5.62 Million | €-495.40K | €6.92 Million |
| Investing Cash Flow | €-3.81 Million | €-1.48 Million | €-1.93 Million | €-4.86 Million | €-4.31 Million |
| Financing Cash Flow | €-4.88 Million | €-3.50 Million | €-4.60 Million | €-5.89 Million | €-5.95 Million |
| Dividends Paid | €3.81 Million | €2.54 Million | €3.79 Million | €5.03 Million | €5.03 Million |
| Stock-Based Compensation | — | — | — | — | €1.00K |
| Depreciation | €2.78 Million | €2.43 Million | €4.87 Million | €2.89 Million | €2.45 Million |
| Change in Cash | €-2.54 Million | €2.66 Million | €976.12K | €-4.80 Million | €675.10K |
DocCheck AG Earnings History — EPS Actual vs. Analyst Estimates
Track DocCheck AG's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jun 30, 2018 | 0.13 | — | — |
| Dec 31, 2010 | 0.01 | — | — |
| Sep 30, 2010 | 0.02 | — | — |
| Jun 30, 2010 | 0.03 | — | — |
| Mar 31, 2010 | 0.08 | — | — |
| Jun 30, 2009 | 0.04 | — | — |
| Mar 31, 2009 | 0.02 | — | — |
| Jun 30, 2008 | 0.03 | — | — |